From: Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
Galectin (Gal) | Cancer type | Effect | Mechanisms | Refs |
---|---|---|---|---|
Gal-1 | Glioma, breast, ovarian, cervical, pancreas, prostate, thyroid, colorectal, lung, melanoma, neuroblastoma, hepatic, gastric, bladder | Increases cell growth, migration, invasion, angiogenesis, metastasis and chemotherapy resistance, induces tumor immune evasion, promotes tumor progression, inhibits apoptosis | Interacts with glycoconjugates and regulates the biological activities of H-Ras/MEK/ERK, β-catenin pathways in the tumor microenvironment | |
Gal-3 | Glioma, breast, ovarian, cervical, pancreas, prostate, thyroid, colorectal, liver, lung, melanoma, neuroblastoma, bladder, gastric, tongue, renal | Increases metastasis formation, reduces apoptosis and induces tumor immune evasion, increase adhesion, tumor growth and motility, induces chemoresistance, cell proliferation, angiogenesis and migration, regulate cell cycle and cell transformation | Regulates M2 polarization of macrophages and triggers apoptosis via its binding to antitumor T cells. Induces the expression of matrix metalloproteinases through p38-MAPK pathway. Maintains mitochondrial homeostasis and regulates tumor metabolism | |
Gal-8 | Glioma, breast, ovarian, prostate, thyroid, colon, liver, lung, bladder, renal, laryngeal | Mediates cell adhesion, migration, proliferation and survival | Binds to integrins and activates the downstream FAK pathway, interacts with activated leukocyte cell adhesion molecule receptors | |
Gal-9 | Glioma, breast, ovarian, cervical, pancreas, prostate, colon, liver, lung, melanoma, renal, oral, myeloma, cholangiocarcinoma, esophageal | Affects cell adhesion and metastasis, induces apoptosis | Regulates JNK and p38 MAP kinase pathways, mitochondrial pathway, blocks adhesion to endothelium and extracellular matrices | |
Gal-4 | Glioma, breast, ovarian, cervical, pancreas, colorectal, liver, lung | Promotes adhesion, reduces cell migration and metastasis formation, induces cell cycle arrest | Interacts with and down-regulates the functions of Wnt signaling pathway. Interferes with the integrin beta 4/Src/FAK cascade | |
Gal-7 | Breast, ovarian, colon, cervical, neuroblastoma, melanoma, gastric, urothelial, thyroid | Correlates with cell proliferation, migration, infiltration and chemosensitivity | Inhibits the TGF beta/Smad3 pathway | |
Gal-2 | Breast, colon | Increases adhesion | Unclear | |
Gal-12 | Cervical, colorectal | Reduces cell growth | Binds to SLC1A5 and inhibits glutamine anaplerosis | [83] |